
Publication
Canada’s new defence investment strategy: Key legal context for defence contractors
On June 9, 2025, Canada’s Prime Minister announced the government’s plan to increase and accelerate Canada’s investments in defence.
The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.
On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]
Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."
Publication
On June 9, 2025, Canada’s Prime Minister announced the government’s plan to increase and accelerate Canada’s investments in defence.
Publication
On April 16, 2025, the Québec Court of Appeal dismissed the appeal of Martin Dionne against Hexo Corp. and Sébastien St-Louis, its former chief executive officer, affirming the Superior Court's decision to deny authorization for a securities class action .
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025